Taxane
Showing 1 - 25 of 990
Breast Tumors, Breast Cancer Trial in Houston, Sugar Land (Paclitaxel, Docetaxel, Abraxane)
Vitamin D Deficiency, Peripheral Neuropathy Trial (Vitamin D)
Not yet recruiting
- Vitamin D Deficiency
- Peripheral Neuropathy
- Vitamin D
- (no location specified)
May 2, 2023
Triple-negative Breast Cancer Trial (Taxane and Carboplatin, Short-term Sintilimab, Surgery)
Not yet recruiting
- Triple-negative Breast Cancer
- Taxane and Carboplatin
- +2 more
- (no location specified)
Apr 25, 2023
Chemo-induced Peripheral Neuropathy Trial in New York (Cannabinoids)
Terminated
- Chemotherapy-induced Peripheral Neuropathy
-
New York, New York1051 Riverside Drive
Jan 3, 2023
CIPN - Chemo-Induced Peripheral Neuropathy Trial (The home-based extremity exercise program)
Not yet recruiting
- CIPN - Chemotherapy-Induced Peripheral Neuropathy
- The home-based extremity exercise program
- (no location specified)
Nov 30, 2022
Breast Carcinoma Trial in Jacksonville (Medical Device Usage and Evaluation, Questionnaire Administration)
Active, not recruiting
- Breast Carcinoma
- Medical Device Usage and Evaluation
- Questionnaire Administration
-
Jacksonville, FloridaMayo Clinic in Florida
Dec 12, 2022
CIPN - Chemo-Induced Peripheral Neuropathy, Breast Cancer Trial in Copenhagen (Elasto-Gel™ mitts for hands: TM7008, and slippers
Recruiting
- CIPN - Chemotherapy-Induced Peripheral Neuropathy
- Breast Cancer
- Elasto-Gel™ mitts for hands: TM7008, and slippers for feet: SL3000; Southwest Technologies, Inc., North Kansas City, MO, USA
-
Copenhagen, DenmarkMaria E Lendorf
Jun 23, 2023
Predictive fActors for toleraNce to Taxane Based CHemotherapy In
Completed
- Elderly Patients
- Metastatic Prostate Cancer
- Taxane chemotherapy
-
Florence, ItalyAOU Careggi Radiation Oncology Unit
Jul 21, 2022
Peripheral Neuropathy Due to Chemo Trial in Cairo (Losartan)
Recruiting
- Peripheral Neuropathy Due to Chemotherapy
-
Cairo, EgyptBreast Cancer Comprehensive Center of the National Cancer Instit
Nov 26, 2023
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- [177Lu]Lu-PSMA-617
- +3 more
- (no location specified)
Jan 23, 2023
HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane Trial in
Recruiting
- HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane
- SHR-A1811
- Pyrotinib in combination with Capecitabine.
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Aug 8, 2022
Neuropathic Pain Trial in Richmond (Ergocalciferol Capsules, Cholecalciferol Capsules)
Not yet recruiting
- Neuropathic Pain
- Ergocalciferol Capsules
- Cholecalciferol Capsules
-
Richmond, VirginiaVirginia Commonwealth University
Jun 16, 2022
Breast Cancer, Taxane-Induced Peripheral Neuropathy Trial in United States (Real Acupuncture, Sham Acupuncture)
Recruiting
- Breast Cancer
- Taxane-Induced Peripheral Neuropathy
- Real Acupuncture
- Sham Acupuncture
-
Basking Ridge, New Jersey
- +6 more
Jul 11, 2022
Chemotherapeutic Toxicity Trial (Home Based Walking Program)
Not yet recruiting
- Chemotherapeutic Toxicity
- Home Based Walking Program
- (no location specified)
Aug 28, 2023
Breast Cancer Trial (Epidiferphane, Taxane Chemotherapy)
Recruiting
- Breast Cancer
- Epidiferphane
- Taxane Chemotherapy
-
Gainesville, FloridaUniversity of Florida
Jan 4, 2023
Breast Tumors, Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (Taxane plus Intermittent Capecitabine, Utidelone
Not yet recruiting
- Breast Neoplasms
- Locally Advanced or Metastatic Breast Cancer
- Taxane plus Intermittent Capecitabine
- +3 more
-
Guangzhou, Guangdong, ChinaShusen Wang
Dec 27, 2021
Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)
Not yet recruiting
- Metastatic Malignant Solid Neoplasm
- Refractory Malignant Solid Neoplasm
- Biopsy
- +5 more
- (no location specified)
Nov 8, 2022
Pain Syndrome Trial in Guangzhou (Etoricoxib)
Completed
- Pain Syndrome
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Jan 29, 2022
TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- (no location specified)
May 8, 2023
HER2-negative Advanced Gastric Cancer Trial in Shanghai (Lenvatinib plus taxane drugs)
Recruiting
- HER2-negative Advanced Gastric Cancer
- Lenvatinib plus taxane drugs
-
Shanghai, Shanghai, ChinaRuijin Hospital
Dec 26, 2021
NSCLC Trial in Philadelphia (Carboplatin, Paclitaxel, Ramucirumab)
Recruiting
- Non-small Cell Lung Cancer
- Carboplatin
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Mar 14, 2022
Advanced Solid Tumors, NSCLC Trial in Hackensack (BMS-986442, Nivolumab, Docetaxel)
Not yet recruiting
- Advanced Solid Tumors
- Non-small Cell Lung Cancer
- BMS-986442
- +5 more
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Sep 14, 2022